Feature Channels: Infectious Diseases

Filters close
Released: 3-Dec-2021 4:20 PM EST
COVID-19 infection can be inhibited by elements of the human microbiome
American Society for Microbiology (ASM)

Researchers have identified metabolites, intermediate or end products of metabolism, in the human microbiome that inhibit COVID-19 infection in cell-based models of the virus.

Released: 3-Dec-2021 3:45 PM EST
Claim that people who are fully vaccinated against COVID-19 are global superspreaders of the new omicron variant is misleading
Newswise

Kim Iversen, a popular political talk show host with over 27K followers on Twitter, claimed that people who are fully vaccinated against COVID-19 are global superspreaders of the new omicron variant. “I can’t believe that after fully vaccinated travelers have been found to be the global spreaders of the omicron variant, we’re STILL talking about forcing people into being vaccinated,” she wrote on Twitter. We find this claim to be misleading. There is very little data on how the new variant is being spread.

Newswise: New vaccine ingredient shows promise
2-Dec-2021 8:05 PM EST
New vaccine ingredient shows promise
La Jolla Institute for Immunology

Scientists at La Jolla Institute for Immunology (LJI) and Massachusetts Institute of Technology (MIT), have found a possible way to improve the effectiveness of COVID-19 vaccines—and any vaccine.

Newswise: Chula Expects the “ChulaCov19” mRNA vaccine and “Chula-Baiya” Protein Subunit Vaccine to Be Ready in 2022
Released: 3-Dec-2021 8:55 AM EST
Chula Expects the “ChulaCov19” mRNA vaccine and “Chula-Baiya” Protein Subunit Vaccine to Be Ready in 2022
Chulalongkorn University

November 18, 2021 – Chulalongkorn University held Chula The Impact 5 Seminar on “The Progress on ChulaCov19 — an mRNA vaccine by Thais — the World’s Hope“. Also discussed was the progress of Chula-Baiya, Thailand’s first protein subunit vaccine from tobacco leaves by Baiya Phytofarm Co., Ltd., and Faculty of Pharmaceutical Sciences, Chulalongkorn University.

Newswise: Hospitals Have Ethical Obligation to Care for Unvaccinated Severe COVID-19 Patients
2-Dec-2021 8:00 AM EST
Hospitals Have Ethical Obligation to Care for Unvaccinated Severe COVID-19 Patients
American Thoracic Society (ATS)

A new opinion piece published online in the Annals of the American Thoracic Society provides an exhaustive examination of the ethics of using hospital resources on unvaccinated-by-choice COVID-19 pneumonia patients, versus patients with other serious illnesses whose diseases are not progressing as quickly.

Newswise: Evasive Maneuvers
Released: 2-Dec-2021 4:50 PM EST
Evasive Maneuvers
Harvard Medical School

New study models future SARS-CoV-2 mutations and forecasts their ability to evade immune defenses developed by vaccines and antibody-based treatments.

Released: 2-Dec-2021 4:25 PM EST
The Omicron Variant: What We Know So Far
Children's Hospital Los Angeles

Just as families are making holiday plans and vaccines are rolling out for children ages 5 to 11, the world is suddenly on high alert about Omicron, a new coronavirus variant that is circulating around the globe.

Newswise:Video Embedded immune-compromised-absolutely-should-boost-covid-19-vaccine-doses
VIDEO
Released: 1-Dec-2021 10:45 AM EST
Immune-Compromised ‘Absolutely’ Should Boost COVID-19 Vaccine Doses
Cedars-Sinai

Patients whose immune systems are weakened due to cancer, organ or bone marrow transplants, chronic diseases, or the medications used to treat these conditions may feel like they have enough on their plates without worrying about whether and when they should take an additional dose of COVID-19 vaccine and a flu shot.

30-Nov-2021 2:45 PM EST
COVID-19 pandemic puts spotlight on science misinformation ‘triggers’
University of Sydney

Pandemic highlights existing issues in our health information ecosystem.

Newswise: First long-acting option HIV prevention approved for use - Worlds AIDS Day
30-Nov-2021 10:05 AM EST
First long-acting option HIV prevention approved for use - Worlds AIDS Day
Queen's University Belfast

The first long-acting option to protect women from HIV, proven to reduce women’s HIV risk, has been recommended for use by the World Health Organization (WHO).

Released: 30-Nov-2021 5:10 PM EST
Study recognizes best way to communicate the importance of vaccinations during pregnancy
Boston University School of Medicine

Vaccine hesitancy is considered one of the top 10 threats to public health by the World Health Organization.

Newswise: On World AIDS Day, COVID-19 Vaccines Are Critical
Released: 30-Nov-2021 4:00 PM EST
On World AIDS Day, COVID-19 Vaccines Are Critical
American Thoracic Society (ATS)

Dec. 1, 2021— People living with HIV experience more severe outcomes and have higher comorbidities from COVID-19 than people not living with HIV, according to the 2020 UNAIDS Global Update. In mid-2021, most people living with HIV did not have access to COVID-19 vaccines. This World AIDS Day, the Forum of International Respiratory Societies (FIRS), of which the American Thoracic Society is a founding member, is calling on governments, health advocates and non-government organisations to strengthen their response to AIDS and COVID-19 by making COVID-19 vaccines more accessible worldwide.

Released: 30-Nov-2021 3:50 PM EST
Mount Sinai Researchers Delineate Novel COVID-19 Subgroups in Critically Ill Patients
Mount Sinai Health System

Mount Sinai researchers have delineated four new subgroups of COVID-19 that can be identified in patients within 24 hours of admission to the intensive care unit (ICU). The finding will help match patients to specific treatments, improving their overall care and outcomes.

Released: 30-Nov-2021 11:05 AM EST
COVID-19 Disparities Caused by Chronic Conditions and Lack of Health Care Access
Rutgers University-New Brunswick

The reason some people get COVID-19, face hospitalization and die may have more to do with underlying health conditions, where they were born, live and work, and their access to testing and care, according to a new Rutgers study.

Released: 29-Nov-2021 11:50 AM EST
Study finds relationship between immune pathway response to influenza and genetic ancestry
University of Chicago Medical Center

High levels of European ancestry are associated with an increase in type I interferon pathway activity in early infection

Released: 29-Nov-2021 10:10 AM EST
DCRI, UNC Center for Health Equity Research, and Partners Launch Free Testing Project to Slow the Spread of COVID-19 with Scalable, Community-Engaged Research
Duke Clinical Research Institute

The Duke Clinical Research Institute (DCRI), Center for Health Equity Research at UNC-Chapel Hill (UNC-CHER), and Community-Campus Partnerships for Health (CCPH) today announced plans to deliver their You & Me COVID-Free testing project in Merced County, Calif., in partnership with United Way.

Released: 29-Nov-2021 9:00 AM EST
Mount Sinai Named a Lead Site for Enrollment in Nationwide Study on the Long-Term Effects of COVID-19
Mount Sinai Health System

The Icahn School of Medicine at Mount Sinai will serve as a hub site for two cohort studies contributing to a nationwide health consortium study by the National Institutes of Health (NIH) on the long-term effects of SARS-CoV-2, the virus that causes COVID-19.

Released: 29-Nov-2021 8:05 AM EST
Rutgers Expanding Enrollment of Participants for Pfizer COVID-19 Pediatric Vaccine Clinical Trial
Rutgers University-New Brunswick

Rutgers, a clinical trial site for the global Pfizer-BioNTech research study to evaluate the efficacy of its COVID-19 vaccine in children, is looking for participants for a third clinical trial on children ages 6 months to 4 years.

24-Nov-2021 12:45 PM EST
COVID-19: Measuring viral RNA to predict which patients will die
Universite de Montreal

A statistical model developed by Université de Montréal researchers uses a blood biomarker of SARS-CoV-2 to identify infected patients who are most at risk of dying of COVID-19.

Released: 24-Nov-2021 5:00 PM EST
Antibodies mimicking the virus may explain long haul COVID-19, rare vaccine side effects
UC Davis Health

A new article published in The New England Journal of Medicine suggests that secondary antibodies known as “anti-idiotype antibodies” could be responsible for some of the side effects of COVID-19 vaccines and the symptoms of long-haul COVID.

Released: 24-Nov-2021 11:05 AM EST
Researchers Find COVID-19 Infection During Pregnancy Leads to Distinct Immune Changes in Mothers and Babies
Cleveland Clinic

In a collaborative study, Cleveland Clinic researchers sought to understand how COVID-19 infection affects pregnant mothers and their children. They published the results of their clinical study in Cell Reports Medicine.

Released: 23-Nov-2021 3:25 PM EST
Researchers investigate ways to reduce COVID-19 risks in dental offices 
University of Illinois Chicago

According to a study from the University of Illinois Chicago, adding a small amount of hydrogen peroxide to the water in ultrasonic scalers used to clean teeth can help mitigate the risk of spreading airborne diseases, including COVID-19, in clinical dental environments.

Newswise: Scientists Find SARS CoV-2-Related Coronaviruses in Cambodian Bats from 2010
Released: 23-Nov-2021 3:10 PM EST
Scientists Find SARS CoV-2-Related Coronaviruses in Cambodian Bats from 2010
Wildlife Conservation Society

A team of scientists have identified coronaviruses closely related to SARS-CoV-2 from two bats sampled in Cambodia more than a decade ago.

Newswise: Exposure to harmless coronaviruses boosts SARS-CoV-2 immunity
Released: 23-Nov-2021 12:45 AM EST
Exposure to harmless coronaviruses boosts SARS-CoV-2 immunity
University of Zurich

The population’s immunity to SARS-CoV-2, achieved either through infection or vaccination, is crucial to overcome the COVID-19 pandemic.

Newswise: When the going gets tough: Challenges faced by healthcare workers during COVID-19 pandemic
Released: 22-Nov-2021 5:45 PM EST
When the going gets tough: Challenges faced by healthcare workers during COVID-19 pandemic
Osaka University

In the early stages of the COVID-19 pandemic, while many of us remained in the safety of our own homes, frontline healthcare workers faced a sudden influx of patients with the new, highly contagious, life-threatening disease.

Newswise: Hospital Retaliates by Suspending Top ICU Dr. for Lawsuit He Filed to use Safe & Effective Treatments on COVID-19
Patients
Released: 22-Nov-2021 5:00 PM EST
Hospital Retaliates by Suspending Top ICU Dr. for Lawsuit He Filed to use Safe & Effective Treatments on COVID-19 Patients
Front Line COVID-19 Critical Care Alliance (FLCCC Alliance)

Paul Marik, MD, one of the world’s leading critical care physicians and the Director of the ICU at Sentara Norfolk General Hospital, part of Sentara Healthcare, was in a Virginia courtroom fighting to treat critically ill COVID-19 patients while his employer was placing a letter notifying him of suspension of hospital privileges on his desk in his hospital office.

Newswise:Video Embedded covid-gets-airborne
VIDEO
Released: 22-Nov-2021 3:40 PM EST
COVID Gets Airborne
University of California San Diego

In May 2021, the Centers for Disease Control officially recognized that SARS-CoV-2 is airborne. Now UC San Diego Professor Rommie Amaro has modeled the delta virus inside an aerosol for the first time.

Newswise: booster-850.jpg
Released: 22-Nov-2021 3:20 PM EST
Breaking Down Boosters
Harvard Medical School

A vaccine booster is readied for use.

Released: 22-Nov-2021 1:50 PM EST
COVID-19 Testing Kits Also Can Measure Oral Microbiome in Saliva
Rutgers University-New Brunswick

COVID-19 saliva testing kits that include a novel preservative can also be used measure microscopic organisms in the mouth, a Rutgers study found. This enables study of the relationship between mouth and lung microbes and the SARS-CoV-2 virus that may allow for the development of new treatments.

Newswise: COVID-19 tracking efforts led by WVU emphasize need for investment in public health
Released: 22-Nov-2021 11:55 AM EST
COVID-19 tracking efforts led by WVU emphasize need for investment in public health
West Virginia University

Efforts from West Virginia University's School of Public Health to help track the spread of COVID-19 through contact tracing, mapping, wastewater monitoring and more played a pivotal role in West Virginia’s response to the pandemic. Yet, work by faculty members also emphasized the need for public and private investments in research, training and infrastructure to ensure better delivery of health care and save lives in the future.

Released: 22-Nov-2021 9:00 AM EST
Success of ivermectin in preventing COVID-19 in India has not been proven
Newswise

While cases appear to have fallen in Uttar Pradesh as well as most locations in India, it’s not clear why. Many other factors, including immunity from a previous infection, vaccination, and lockdowns, likely helped reduce the number of cases.

Released: 22-Nov-2021 8:05 AM EST
No extra COVID-19 risk for ECMO transport teams, reports ASAIO Journal
Wolters Kluwer Health: Lippincott

Critically ill patients with COVID-19 can safely be transported for lifesaving extracorporeal membrane oxygenation (ECMO) therapy – with no increased risk of transmitting COVID-19 transmission to ECMO transport team members following standard precautions, reports a study in the ASAIO Journal, official journal of the American Society for Artificial Internal Organs. The journal is published in the Lippincott portfolio by Wolters Kluwer.

Released: 19-Nov-2021 4:05 PM EST
Physician Parents Step Up to Vaccinate Their Children
Cedars-Sinai

Cedars-Sinai physicians who have been on the front lines in the battle against COVID-19 in the community are also doing their part at home by getting their children vaccinated against the virus.

Released: 19-Nov-2021 2:25 PM EST
Unborn babies could contract Covid-19 says study, but it would be uncommon
University College London

An unborn baby could become infected with Covid-19 if their gut is exposed to the SARS-CoV-2 virus, finds a new study led by UCL researchers with Great Ormond Street Hospital for Children and the NIHR Great Ormond Street Biomedical Research Centre.

Released: 19-Nov-2021 2:10 PM EST
Plant-derived antiviral drug is effective in blocking highly infectious SARS-CoV-2 Delta variant, say scientists
University of Nottingham

A plant-based antiviral treatment for Covid-19, recently discovered by scientists at the University of Nottingham, has been found to be just as effective at treating all variants of the virus SARS-CoV-2, even the highly infectious Delta variant.

Released: 19-Nov-2021 12:55 PM EST
COVID-19 vaccine elicits weak antibody response in people taking immunosuppressant
Washington University in St. Louis

People taking TNF inhibitors, a kind of immunosuppressive drug used to treat rheumatoid arthritis and other autoimmune conditions, produced a weaker and shorter-lived antibody response after two doses of Pfizer's COVID-19 vaccine, according to a study from Washington University School of Medicine in St. Louis. A third vaccine dose drove antibody levels back up, indicating that this additional dose may provide protection as the virus's delta variant continues to spread.

Newswise: Age, sex and waning COVID-19 antibodies
Released: 19-Nov-2021 12:30 PM EST
Age, sex and waning COVID-19 antibodies
Texas Biomedical Research Institute

As widely-anticipated decisions about COVID-19 vaccine boosters roll out from U.S. agencies today, insights from an independent study underscore why boosters are important for all adults.

Released: 18-Nov-2021 11:55 AM EST
Optimized second-generation mRNA vaccine demonstrated improved protection against COVID-19 in preclinical testing
Beth Israel Deaconess Medical Center

Researchers at Beth Israel Deaconess Medical Center (BIDMC) conducted a head-to-head test of the second-generation vaccine CV2CoV compared with CVnCoV. The scientists assessed the vaccines’ ability to provoke an immune response as well as their protective efficacy against COVID-19 in non-human primates.

Newswise: Did the US COVID-19 Vaccine Strategy Work?
11-Nov-2021 1:30 PM EST
Did the US COVID-19 Vaccine Strategy Work?
PLOS

The CDC’s vaccine prioritization strategy performed well compared to other approaches, though with some room for improvement

Newswise: Many older Americans plan to take long trips soon, but may alter plans if COVID spikes at their destination
16-Nov-2021 9:00 AM EST
Many older Americans plan to take long trips soon, but may alter plans if COVID spikes at their destination
Michigan Medicine - University of Michigan

Nearly one in three older adults plans a long trip far from home in the next year, and many look forward to holiday travel in the next two months, a new poll finds. But many said they would consider local COVID-19 case rates at their destination.

Released: 16-Nov-2021 5:05 PM EST
Common Gene Variants Linked to Sepsis and COVID-19 Severity in African Americans
Perelman School of Medicine at the University of Pennsylvania

Two genetic risk variants that are carried by nearly 40 percent of Black individuals may exacerbate the severity of both sepsis and COVID-19, a team of researchers from the University of Pennsylvania’s Perelman School of Medicine have found.

Released: 16-Nov-2021 3:40 PM EST
Air filter significantly reduces presence of airborne SARS-CoV-2 in COVID-19 wards
University of Cambridge

When a team of doctors, scientists and engineers at Addenbrooke’s Hospital and the University of Cambridge placed an air filtration machine in COVID-19 wards, they found that it removed almost all traces of airborne SARS-CoV-2.

Released: 16-Nov-2021 2:55 PM EST
Outcomes for Hospitalized COVID-19 Patients Taking Immunosuppressive Medications Similar to Non-Immunosuppressed Patients
Johns Hopkins Bloomberg School of Public Health

The study found that overall, hospitalized COVID-19 patients taking immunosuppressive drugs did not face increased risk of death or being put on a ventilator compared with non-immunosuppressed hospitalized COVID-19 patients.

Newswise: One in five vaccinated long-term care residents were at risk of COVID because of low antibody levels, supporting need for booster shots
Released: 16-Nov-2021 12:20 PM EST
One in five vaccinated long-term care residents were at risk of COVID because of low antibody levels, supporting need for booster shots
McMaster University

New research from McMaster University, aimed at understanding the immune response to COVID-19 vaccines, found some long-term care residents no longer had high antibody levels months after their second dose, directly supporting government decisions to provide third doses.

Released: 16-Nov-2021 9:00 AM EST
Unraveling the pseudoknot: Research to explore the ‘switch’ behind COVID virus
Binghamton University, State University of New York

Binghamton University Chemistry Professor Eriks Rozners has received a two-year $428,330 grant from the National Institute of Allergy and Infectious Diseases for a research project which explores the "switch" behind the coronavirus.


Showing results

150 of 10259

close
4.10465